Skip to main content
. 2009 Jun 19;32(9):1663–1668. doi: 10.2337/dc09-0533

Figure 1.

Figure 1

Enrollment and outcome. Of the 70 patients who underwent randomization, 67 completed 13 weeks of anakinra or placebo treatment and were included in the present 39-week follow-up study. Of the former anakinra- and placebo-treated patients, 33 and 31, respectively, completed the study.